• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pilomatrix-like High-grade Endometrioid Carcinoma is a Morphologically and Immunophenotypically Distinct Entity and May Show Mismatch Repair Deficiency.

作者信息

Arciuolo Damiano, Travaglino Antonio, Santoro Angela, Roberti Paola, Raffone Antonio, Inzani Frediano, Zannoni Gian Franco

出版信息

Int J Gynecol Pathol. 2023 Jan 1;42(1):68-69. doi: 10.1097/PGP.0000000000000859. Epub 2022 Feb 18.

DOI:10.1097/PGP.0000000000000859
PMID:35180769
Abstract
摘要

相似文献

1
Pilomatrix-like High-grade Endometrioid Carcinoma is a Morphologically and Immunophenotypically Distinct Entity and May Show Mismatch Repair Deficiency.毛母质瘤样高级别子宫内膜样癌是一种在形态学和免疫表型上独特的实体，可能表现为错配修复缺陷。
Int J Gynecol Pathol. 2023 Jan 1;42(1):68-69. doi: 10.1097/PGP.0000000000000859. Epub 2022 Feb 18.
2
An Expanded Series of Pilomatrix-like High-grade Endometrioid Carcinoma (PiMHEC), Including Both MMR Deficient and MMR Proficient Cases.一组扩大的毛母质瘤样高级别子宫内膜样癌（PiMHEC）病例系列，包括错配修复缺陷和错配修复 proficient 病例。（注：“proficient”直译为“熟练的、精通的”，在医学语境中结合前文推测这里想表达“错配修复功能正常的”，但按要求不添加解释，直接保留英文）
Int J Gynecol Pathol. 2024 Jan 1;43(1):67-69. doi: 10.1097/PGP.0000000000000955. Epub 2023 May 5.
3
The first evidence of mismatch repair deficiency in mesonephric-like adenocarcinoma of the endometrium: clinicopathological and molecular features of a case emphasising a possible endometrioid carcinogenesis.子宫内膜中肾样腺癌错配修复缺陷的首例证据：一例病例的临床病理及分子特征，强调可能的子宫内膜样癌发生机制
Histopathology. 2024 May;84(6):1068-1070. doi: 10.1111/his.15136. Epub 2024 Jan 3.
4
Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.错配修复缺陷可识别高风险（HIR）子宫内膜样子宫内膜癌患者中复发风险最高的患者：一种预后生物标志物。
Cancer. 2019 Feb 1;125(3):398-405. doi: 10.1002/cncr.31901. Epub 2018 Dec 18.
5
Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma.激素受体作用的分子调节剂：错配修复缺陷型子宫内膜样腺癌中雄激素受体表达降低
Int J Gynecol Pathol. 2019 Jan;38(1):44-51. doi: 10.1097/PGP.0000000000000465.
6
CTNNB1 -mutated High-grade Endometrioid Carcinoma With Extensive Squamous and Shadow Cell Differentiation Can Mimic Pilomatrix Carcinoma.伴有广泛鳞状和影细胞分化的CTNNB1突变型高级别子宫内膜样癌可模仿毛母质癌。
Int J Gynecol Pathol. 2023 May 1;42(3):325-326. doi: 10.1097/PGP.0000000000000888. Epub 2022 May 20.
7
Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas.PTEN、DNA 错配修复与子宫内膜癌组织学分型的关系：PTEN 阳性表达的保留更倾向于识别散发性非子宫内膜样癌。
Mod Pathol. 2013 Oct;26(10):1401-12. doi: 10.1038/modpathol.2013.67. Epub 2013 Apr 19.
8
Mismatch repair in endometrioid endometrial cancer: Increasing our therapeutic proficiency by capitalizing on molecular deficiency.子宫内膜样子宫内膜癌中的错配修复：利用分子缺陷提高我们的治疗水平。
Cancer. 2019 Feb 1;125(3):337-339. doi: 10.1002/cncr.31902. Epub 2018 Dec 18.
9
Clinicopathological features of 50 mismatch repair (MMR)-deficient endometrial carcinomas, tested by immunohistochemistry: A single institutional feasibility study, India.50 例免疫组织化学检测错配修复（MMR）缺陷型子宫内膜癌的临床病理特征：印度单机构可行性研究。
Ann Diagn Pathol. 2020 Aug;47:151558. doi: 10.1016/j.anndiagpath.2020.151558. Epub 2020 Jun 20.
10
Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.在普遍进行林奇综合征筛查的时代，错配修复缺陷型子宫内膜癌患者的临床病理特征和结局。
Gynecol Oncol. 2020 Dec;159(3):712-720. doi: 10.1016/j.ygyno.2020.09.039. Epub 2020 Oct 10.

引用本文的文献

1
Uterine endometrioid adenocarcinoma with pilomatrix-like differentiation: A case report and review of the literature.具有毛母质瘤样分化的子宫内膜样腺癌：一例报告并文献复习
Gynecol Oncol Rep. 2025 Feb 9;57:101693. doi: 10.1016/j.gore.2025.101693. eCollection 2025 Feb.
2
Beyond the WHO 2020 Classification of Female Genital Tumors: Types of Endometrial Cancer: A Pathological and Molecular Focus on Challenging Rare Variants.超越世卫组织 2020 年女性生殖器官肿瘤分类：子宫内膜癌的类型：一种对罕见变异型具有挑战性的病理和分子焦点。
Int J Mol Sci. 2024 Sep 25;25(19):10320. doi: 10.3390/ijms251910320.
3
Endometrial endometrioid adenocarcinoma with a malignant squamous component: is the unusual metastatic pattern unique of these tumors?
伴有恶性鳞状成分的子宫内膜样腺癌：这种不寻常的转移模式是这些肿瘤所特有的吗？
Virchows Arch. 2024 Dec;485(6):1085-1094. doi: 10.1007/s00428-024-03828-2. Epub 2024 Jun 22.
4
Ovarian Endometrioid Adenocarcinomas With Infiltrative "Adenofibroma-like" Morphology and Aberrant ß-catenin Expression: Tumors That Coexpress CDX2 and LEF1 With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible Association With Endometrioid Type II Stem Cell Outgrowths in the Fallopian Tube.具有浸润性“腺纤维瘤样”形态及异常β-连环蛋白表达的卵巢子宫内膜样腺癌：共表达CDX2和LEF1且神经内分泌标志物表达频繁、PAX8表达减少/缺失以及可能与输卵管中II型子宫内膜样干细胞生长相关的肿瘤
Int J Gynecol Pathol. 2024 Mar 1;43(2):145-148. doi: 10.1097/PGP.0000000000000989. Epub 2023 Sep 22.
5
An Expanded Series of Pilomatrix-like High-grade Endometrioid Carcinoma (PiMHEC), Including Both MMR Deficient and MMR Proficient Cases.一组扩大的毛母质瘤样高级别子宫内膜样癌（PiMHEC）病例系列，包括错配修复缺陷和错配修复 proficient 病例。（注：“proficient”直译为“熟练的、精通的”，在医学语境中结合前文推测这里想表达“错配修复功能正常的”，但按要求不添加解释，直接保留英文）
Int J Gynecol Pathol. 2024 Jan 1;43(1):67-69. doi: 10.1097/PGP.0000000000000955. Epub 2023 May 5.
6
Pilomatrix-like High-Grade Endometrioid Carcinoma of the Ovary: Case Report, Literature Review, and Differential Diagnosis.卵巢毛母质瘤样高级别子宫内膜样癌：病例报告、文献综述及鉴别诊断
Diagnostics (Basel). 2022 Dec 13;12(12):3146. doi: 10.3390/diagnostics12123146.